2008 APS March Meeting
Volume 53, Number 2
Monday–Friday, March 10–14, 2008;
New Orleans, Louisiana
Session X15: Emerging Nano-based Diagnostics and Therapeutics: Approaches to Cancer Treatment
8:00 AM–11:00 AM,
Friday, March 14, 2008
Morial Convention Center
Room: 207
Sponsoring
Units:
DBP FIAP
Chair: Larry Nagahara, National Cancer Institute
Abstract ID: BAPS.2008.MAR.X15.4
Abstract: X15.00004 : Magnetic sifters and biochips for early diagnosis and therapy monitoring of cancer
9:48 AM–10:24 AM
Preview Abstract
Abstract
Author:
Chris Earhart
(Stanford University)
Magnetic nanoparticles conjugated with biomolecules or
recognition moieties
are finding wide applications in medicine. In this context, we are
developing a micromachined magnetic sifter and magnetic
nanoparticles aimed
for sample preparation applications in early diagnosis of cancer.
The
microfabricated sifter consisting of arrays of micron sized slits
etched
through a silicon wafer. A magnetic film is deposited on the wafer,
producing high magnetic field gradients, comparable in magnitude to
gradients in planar flow devices. As the solution flows through
the die,
magnetic particles are captured by the magnetic material
surrounding the
slits. The large number of slits allows for processing of large
volumes of
liquid, much greater than that of planar microfluidic devices.
The sifters
can be simply attached to a syringe or tube, resulting in a
portable and
user-friendly tool for molecular biology. Separation efficiencies
of $\sim $
50{\%} for one pass through the sifter have been achieved.
We have also designed and fabricated several types of magnetic
biochips
consisting of arrays of giant magnetoresistive (GMR) spin valve
detectors
with appropriate dimensions, surface chemistry, and
microfluidics. An
advanced electronic test station has been set up as a
demonstration vehicle
for the integrated evaluation of our magnetic biochips with
commercial and
custom magnetic nanoparticle labels for DNA or protein
biomarkers. The
magnetic biochip is capable of detecting down to 1-30 nanotags.
Real-time
detection of DNA signatures and protein targets in buffer and
serum samples
has been successfully performed in our laboratories, suggesting that
magnetic biochips hold great promises for molecular diagnostics
of cancer
and other diseases. In collaboration with Chris M. Earhart, Wei
Hu, Robert J. Wilson, Sebastian J. Osterfeld, Robert
L. White, Nader Pourmand, and Shan X. Wang @ Stanford University.
This work was supported by grants from NIH
(1U54CA119367-01) and DARPA/Navy (N00014-02-1-0807).
To cite this abstract, use the following reference: http://meetings.aps.org/link/BAPS.2008.MAR.X15.4